Ana Castro

First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors:  Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2002 · 447 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacotherapy +13

Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE

D. A. Alonso, Isabel Dorronsoro, Laura Rubio et al. · Bioorganic & Medicinal Chemistry · 2005 · 157 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure–Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s Disease

Mark T. Hamann, D. A. Alonso, Ester Martı́n-Aparicio et al. · Journal of Natural Products · 2007 · 145 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:  Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2005 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3

Daniel I. Pérez, Concepción Pérez, José Á. Morales-García et al. · Journal of Medicinal Chemistry · 2012 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13